Pennant Group, Inc. PNTG
We take great care to ensure that the data presented and summarized in this overview for Pennant Group, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding PNTG
View all-
8 Knots Management, LLC Dallas, TX2.4MShares$71.7 Million11.65% of portfolio
-
Black Rock Inc. New York, NY2.23MShares$66.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.04MShares$61 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD1.4MShares$42 Million0.03% of portfolio
-
Riverbridge Partners LLC1.1MShares$33 Million0.54% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT1.05MShares$31.3 Million0.19% of portfolio
-
Paradigm Capital Management Inc939KShares$28.1 Million1.52% of portfolio
-
Dimensional Fund Advisors LP Austin, TX767KShares$23 Million0.01% of portfolio
-
Crewe Advisors LLC743KShares$22.2 Million3.09% of portfolio
-
Goldman Sachs Group Inc New York, NY722KShares$21.6 Million0.0% of portfolio
Latest Institutional Activity in PNTG
Top Purchases
Top Sells
About PNTG
The Pennant Group, Inc. provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families. It also provides senior living services, such as residential accommodations, activities, meals, housekeeping, and assistance in the activities of daily living to seniors, who are independent or who require some support. As of December 31, 2021, the company operated 88 home health and hospice agencies, and 54 senior living communities with 4127 Senior Living units in Arizona, California, Colorado, Idaho, Iowa, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The Pennant Group, Inc. was incorporated in 2019 and is headquartered in Eagle, Idaho.
Insider Transactions at PNTG
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Oct 23
2024
|
Jo Anne Stringfield Director |
SELL
Open market or private sale
|
Direct |
380
-1.35%
|
$12,540
$33.56 P/Share
|
Oct 15
2024
|
Christopher R. Christensen Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+2.21%
|
-
|
Oct 15
2024
|
Barry M Smith Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,900
+9.07%
|
-
|
Oct 15
2024
|
Stephen M R Covey Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+8.89%
|
-
|
Oct 15
2024
|
Scott E Lamb Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+6.65%
|
-
|
Oct 15
2024
|
John G. Nackel Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+1.83%
|
-
|
Oct 15
2024
|
Gregory K Morris Sr. Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+11.11%
|
-
|
Oct 15
2024
|
Jo Anne Stringfield Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+9.62%
|
-
|
Sep 10
2024
|
Christopher R. Christensen Director |
BUY
Bona fide gift
|
Indirect |
11,927
+1.88%
|
-
|
Sep 10
2024
|
Christopher R. Christensen Director |
SELL
Bona fide gift
|
Direct |
11,927
-8.42%
|
-
|
Aug 27
2024
|
Brent Guerisoli President |
SELL
Open market or private sale
|
Direct |
1,418
-0.86%
|
$48,212
$34.74 P/Share
|
Aug 27
2024
|
Brent Guerisoli President |
BUY
Exercise of conversion of derivative security
|
Direct |
2,515
+1.48%
|
$17,605
$7.42 P/Share
|
Jul 23
2024
|
Jo Anne Stringfield Director |
SELL
Open market or private sale
|
Direct |
380
-0.75%
|
$10,640
$28.0 P/Share
|
Jul 15
2024
|
Jo Anne Stringfield Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+10.5%
|
$78,000
$26.25 P/Share
|
Jul 15
2024
|
Barry M Smith Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,100
+7.57%
|
$132,600
$26.25 P/Share
|
Jul 15
2024
|
Scott E Lamb Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+7.12%
|
$78,000
$26.25 P/Share
|
Jul 15
2024
|
Stephen M R Covey Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+9.76%
|
$78,000
$26.25 P/Share
|
Jul 15
2024
|
John G. Nackel Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+1.86%
|
$78,000
$26.25 P/Share
|
Jul 15
2024
|
Christopher R. Christensen Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+2.07%
|
$78,000
$26.25 P/Share
|
Jul 15
2024
|
Gregory K Morris Sr. Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+12.5%
|
$78,000
$26.25 P/Share
|
Last 12 Months Summary
Grant, award, or other acquisition | 93K shares |
---|---|
Bona fide gift | 11.9K shares |
Exercise of conversion of derivative security | 113K shares |
Bona fide gift | 11.9K shares |
---|---|
Open market or private sale | 3.94K shares |